Femasys (FEMY) Capital Expenditures Growth (1y) (2021 - 2026)
Femasys (FEMY) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -11.41% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 9.65% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -2.04% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 61.83% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -63.39% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 10.63% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 21.73% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.30% |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | -18.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.08% |
| Dec 31, 2025 | 30.95% |
| Sep 30, 2025 | -52.36% |
| Jun 30, 2025 | -48.35% |
| Mar 31, 2025 | 49.64% |
| Dec 31, 2024 | 137.85% |
| Sep 30, 2024 | 1,401.48% |
| Jun 30, 2024 | 189.80% |
| Mar 31, 2024 | 625.28% |
| Dec 31, 2023 | -52.17% |
| Sep 30, 2023 | 46.54% |
| Jun 30, 2023 | -63.97% |
| Mar 31, 2023 | -92.61% |
| Dec 31, 2022 | -20.86% |
| Sep 30, 2022 | -89.45% |
| Jun 30, 2022 | 1,296.18% |
| Sep 30, 2021 | 5,222.02% |